Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Genetic Technologies Ltd (GENE : NSDQ)

• Company Description    Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species. Number of Employees: 52

• Price / Volume Information    Yesterday's Closing Price: $0.96 Daily Weekly Monthly 20 Day Moving Average: 171,920 shares Shares Outstanding: 19.24 (millions) Market Capitalization: $18.46 (millions) Beta: 1.59 52 Week High: $2.40 52 Week Low: $0.83 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.39% -1.49% 12 Week -17.97% -23.86% Year To Date 3.19% -6.13%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 60-66 Hanover Street - Fitzroy,C3 3065 AUS ph: 61-3-8412-7000 fax: 011-61-3-8412-7040 investors@genetype.com http://www.gtglabs.com

• General Corporate Information    Officers Simon Morriss - Chief Executive Officer Peter Rubinstein - Chairman and Director Mike Tonroe - Chief Financial Officer Jerzy Muchnicki - Director Lindsay Wakefield - Director Peer Information Genetic Technologies Ltd (CORR.) Genetic Technologies Ltd (RSPI) Genetic Technologies Ltd (CGXP) Genetic Technologies Ltd (BGEN) Genetic Technologies Ltd (GTBP) Genetic Technologies Ltd (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 37185R307 SIC: 2836 Fiscal Year Fiscal Year End: June Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 19.24 Most Recent Split Date: 8.00 (0.25:1) Beta: 1.59 Market Capitalization: $18.46 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.04 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/23 - - 12/31/22 - - 09/30/22 - - ROA 03/31/23 - - 12/31/22 - - 09/30/22 - - Current Ratio 03/31/23 - - 12/31/22 - 2.08 09/30/22 - - Quick Ratio 03/31/23 - - 12/31/22 - 1.98 09/30/22 - - Operating Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Net Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Pre-Tax Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Book Value 03/31/23 - - 12/31/22 - 0.47 09/30/22 - - Inventory Turnover 03/31/23 - - 12/31/22 - - 09/30/22 - - Debt-to-Equity 03/31/23 - - 12/31/22 - 0.03 09/30/22 - - Debt-to-Capital 03/31/23 - - 12/31/22 - 2.89 09/30/22 - -

Powered by Zacks Investment Research ©